IP Library › Granted Patent US 9,095,494
Granted Patent B2
US 9,095,494 · App. 14/237,857 · Granted Aug 4, 2015

Fluid exchange methods and devices

Inventors: Brian David Warner (Martinez, CA); John Dunne (Livermore, CA)
Assignee: Becton, Dickinson and Company
A61J3/00A61K9/0019A61M1/3678A61M1/3693A61M5/1407A61M5/1413C12N13/00A61M37/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,494
App. No.
14/237,857
Granted
Aug 4, 2015
Kind
B2
Abstract

Methods and devices for exchanging therapeutic agents, such as cells, from one liquid medium to another liquid medium are provided. Aspects of embodiments of the methods include transferring a therapeutic agent from a first medium, such as a freezing, storage or shipping buffer, into a second medium, such as a sterile physiologically compatible buffer. In certain aspects, the transfer of the therapeutic agent from a first medium to a second medium involves the use of acoustic-focusing, or acoustophoresis. Embodiments of the subject methods may facilitate the transfer of a therapeutic agent from a storage medium to an infusion medium, and in certain embodiments include administering the therapeutic agent contained in the infusion medium to the subject. Also provided by the present disclosure are devices for practicing the subject methods.

Claims (10)

1. A method of preparing a particulate infusion composition, the method comprising:

combining a first liquid comprising a therapeutic agent in a storage medium and a second liquid infusion medium in a manner sufficient to produce a laminar flow of the first and second media; and

acoustophoretically moving the therapeutic agent from a first liquid medium into the second liquid medium.

2. The method according to claim 1 , wherein the method further comprises infusing the second liquid medium into a subject.

3. The method according to claim 2 , wherein the subject is human.

4. The method according to claim 2 , wherein the therapeutic agent was obtained from the subject.

5. The method according to claim 1 , wherein the therapeutic agent comprises cells.

6. The method according to claim 1 , wherein the first liquid medium comprises a cryoprotectant.

7. The method according to claim 1 , wherein combining the first and second media comprises gravimetric fluid flow.

8. The method according to claim 1 , wherein the method is performed under sterile conditions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2014
From: WARNER, BRIAN; DUNNE, JOHN F.
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 033288/0392 →
Continuity (2)
Provisional Application 61541870 · Sep 30, 2011
Related Publication 20140193381A1 · Jul 10, 2014